PFBT
RLAY icon

Parkside Financial Bank & Trust’s Relay Therapeutics RLAY Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Hold
129
– – ﹤0.01% 2262
2025
Q4 		$1.09K Hold
129
– – ﹤0.01% 2315
2025
Q3 		$674 Buy
+129
New +$492 ﹤0.01% 2424
2025
Q2 		– Sell
-125
Closed -$327 – 2960
2025
Q1 		$327 Buy
+125
New +$490 ﹤0.01% 2612

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Parkside Financial Bank & Trust's RLAY Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Relay Therapeutics (RLAY) position steady in Q1 2026 at 129 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

Parkside Financial Bank & Trust first reported a position in RLAY in Q1 2025 and has held it in 4 quarters since. 243 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Parkside Financial Bank & Trust held 129 shares of Relay Therapeutics worth $1.28K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Relay Therapeutics share count unchanged in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2262 holding.
  • Parkside Financial Bank & Trust first reported a position in Relay Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 243 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.